Long-Term Real-World Experience of CPX-351 in Combined French-Italian Cohorts Identified High Rate of Negative Measurable Residual Disease (MRD) and Prolonged Overall Survival

Blood, 2023-11, Vol.142 (Supplement 1), p.4255-4255 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-177951

Full text available